Qixin Li
Observed name: Qi-Xin Li
Observed institutions: AstraZeneca (United Kingdom), Guangzhou University of Chinese Medicine, East China University of Science and Technology, Bayer (United States), China National Offshore Oil Corporation (China), National University of Singapore, The University of Western Australia, Shenzhen University, Anhui Medical University, Harbin Institute of Technology, Beijing Normal University, UNSW Sydney, Zhengzhou University, First People's Hospital of Foshan, Chaohu Hospital of Anhui Medical University, Fifth Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xi'an Jiaotong University, Guangdong Academy of Medical Sciences, Fujian Provincial Cancer Hospital, AstraZeneca (United States), Guangdong Provincial People's Hospital, First Hospital of Xi'an, Southern Medical University, Xi'an Jiaotong University
ORCID: 0009-0006-9752-4696
Observed ORCID: 0009-0006-9752-4696
OpenAlex ID: A5103203941
